184 related articles for article (PubMed ID: 17415565)
1. T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies.
Garrido G; Lorenzano P; Sánchez B; Beausoleil I; Alonso DF; Pérez R; Fernández LE
Cancer Immunol Immunother; 2007 Nov; 56(11):1701-10. PubMed ID: 17415565
[TBL] [Abstract][Full Text] [Related]
2. Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.
Garrido G; Rabasa A; Garrido C; López A; Chao L; García-Lora AM; Garrido F; Fernández LE; Sánchez B
Oncogene; 2014 Jun; 33(24):3129-39. PubMed ID: 23975426
[TBL] [Abstract][Full Text] [Related]
3. Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody.
Garrido G; Rabasa A; Sánchez B; López MV; Blanco R; López A; Hernández DR; Pérez R; Fernández LE
J Immunol; 2011 Nov; 187(10):4954-66. PubMed ID: 21984704
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration.
Hoffmann TK; Schirlau K; Sonkoly E; Brandau S; Lang S; Pivarcsi A; Balz V; Müller A; Homey B; Boelke E; Reichert T; Friebe-Hoffmann U; Greve J; Schuler P; Scheckenbach K; Schipper J; Bas M; Whiteside TL; Bier H
Int J Cancer; 2009 Jun; 124(11):2589-96. PubMed ID: 19208382
[TBL] [Abstract][Full Text] [Related]
5. Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer.
Yokouchi H; Yamazaki K; Chamoto K; Kikuchi E; Shinagawa N; Oizumi S; Hommura F; Nishimura T; Nishimura M
Cancer Sci; 2008 Feb; 99(2):361-7. PubMed ID: 18201271
[TBL] [Abstract][Full Text] [Related]
6. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
[TBL] [Abstract][Full Text] [Related]
7. Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma.
Diaz Y; Gonzalez A; Lopez A; Perez R; Vazquez AM; Montero E
Cancer Immunol Immunother; 2009 Jul; 58(7):1117-28. PubMed ID: 19066887
[TBL] [Abstract][Full Text] [Related]
8. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
9. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
10. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
[TBL] [Abstract][Full Text] [Related]
11. 7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies.
Garrido G; Sanchez B; Rodriguez HM; Lorenzano P; Alonso D; Fernandez LE
Hybrid Hybridomics; 2004 Jun; 23(3):168-75. PubMed ID: 15312307
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
Ciardiello F; Damiano V; Bianco R; Bianco C; Fontanini G; De Laurentiis M; De Placido S; Mendelsohn J; Bianco AR; Tortora G
J Natl Cancer Inst; 1996 Dec; 88(23):1770-6. PubMed ID: 8944008
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its F(ab')(2) Fragment in an Immunocompetent Mouse Model.
Rabasa Capote A; González JE; Rodríguez-Vera L; López A; Sánchez Ramírez B; Garrido Hidalgo G
ISRN Pharmacol; 2012; 2012():417515. PubMed ID: 23227357
[TBL] [Abstract][Full Text] [Related]
14. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.
Machlenkin A; Goldberger O; Tirosh B; Paz A; Volovitz I; Bar-Haim E; Lee SH; Vadai E; Tzehoval E; Eisenbach L
Clin Cancer Res; 2005 Jul; 11(13):4955-61. PubMed ID: 16000595
[TBL] [Abstract][Full Text] [Related]
15. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor.
Lu Y; Wei YQ; Tian L; Zhao X; Yang L; Hu B; Kan B; Wen YJ; Liu F; Deng HX; Li J; Mao YQ; Lei S; Huang MJ; Peng F; Jiang Y; Zhou H; Zhou LQ; Luo F
J Immunol; 2003 Mar; 170(6):3162-70. PubMed ID: 12626574
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel theanine derivatives.
Zhang G; Ye X; Ji D; Zhang H; Sun F; Shang C; Zhang Y; Wu E; Wang F; Wu F; Tian H; Liu X; Chen L; Liu K; Wang Y; Liu H; Zhang W; Guan Y; Wang Q; Zhao X; Wan X
Oncotarget; 2014 Sep; 5(18):8528-43. PubMed ID: 25138052
[TBL] [Abstract][Full Text] [Related]
17. Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with
Ohishi T; Kato Y; Kaneko MK; Ohba SI; Inoue H; Harakawa A; Kawada M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839411
[TBL] [Abstract][Full Text] [Related]
18. Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor.
Hu B; Wei Y; Tian L; Zhao X; Lu Y; Wu Y; Yao B; Liu J; Niu T; Wen Y; He Q; Su J; Huang M; Lou Y; Luo Y; Kan B
J Immunother; 2005; 28(3):236-44. PubMed ID: 15838380
[TBL] [Abstract][Full Text] [Related]
19. Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12.
Popovic D; El-Shami KM; Vadai E; Feldman M; Tzehoval E; Eisenbach L
Clin Exp Metastasis; 1998 Oct; 16(7):623-32. PubMed ID: 9932609
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy of head and neck cancer. Identification of a novel mechanism for anti-EGFR mAb anti-tumor effects].
Hoffmann TK
HNO; 2011 Mar; 59(3):224-9. PubMed ID: 21424359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]